Resources
Publications
Download
-
Xarelto Clinical Trials Brochure
14/09/2009 -
Understanding VTE Booklet
08/05/2008
Xarelto News
- Bayer’s Xarelto® (Rivaroxaban) Submitted for EU Marketing Authorisation for Secondary Prevention after an Acute Coronary Syndrome
- Xarelto® Approved in the EU for the Prevention of Stroke in Patients with AF and in the Treatment of DVT
- Bayer’s Xarelto® (Rivaroxaban) Meets Primary Efficacy Endpoint and Shows Significant Reduction in Mortality in Major ACS Study
Other Websites of Interest
-
New England Journal of Medicine - Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
Rivaroxaban was superior to enoxaparin for thromboprophylaxis after total knee arthroplasty, with similar rates of bleeding.
-
ThrombosisManagement CME on TheHeart.org
ThrombosisManagement is a Continuing Medical Education (CME) programme on theheart.org with regular updates.
-
European Medicines Agency - Xarelto® Product Information
Xarelto® Product Information in all official languages of the European Union provided by the European Medicines Agency
Benefit Calculator
Events Calendar
For the Press
Go to the Press Resources page to find more information on Xarelto
